Laser Vaporization of Inoperable Esophageal and Rectal Cancer. Why We Use this Therapy
Journal of Surgery
Volume 3, Issue 1, February 2015, Pages: 4-7
Received: Nov. 3, 2014; Accepted: Dec. 12, 2014; Published: Jan. 23, 2015
Views 2945      Downloads 141
Leszek Stefanski, Department of Gastrointestinal Tract Surgery, Medical University of Silesia, Central Teaching Hospital, 14, Medyków Street, 40-752 Katowice, Poland
Pawel Lampe, The Higher School of Strategic Planning, 6 Koscielna Street, 41-303 Dobrowa Gornicza, Poland
Article Tools
Follow on us
Laser therapy of esophageal or rectal cancer gives opportunity to withdraw temporarily symptoms of dysphagia or obstruction due to immediate vaporization of exophytic part of neoplastic tumor and exfoliation of coagulated deeper tissue. This therapy improves life comfort of patients suffering from esophageal and rectal cancer in cases when radical therapy is impossible. 58 laser vaporization of esophageal cancer in inoperable patients with ASA IV and V were performed from January 2008 to October 2011. 42 suffered from squamous-cell cancer, 16 – from esophageal adenocarcinoma localized endoscopically from 20 to 40 cm, administering 2 – 9 kJ of heat. Also 18 laser vaporisations of rectal cancer were performed, administering 4 - 18 kJ of heat. 1,6 sessions (1-5 sessions) with high-energy laser were performed on average, adjusting laser power for 70 W and performing photo-destruction of the esophageal neoplastic tumor with mortality of 2%. The average for rectal cancer were 1,1 sessions (1-2) with time asymptomatic of subileus from 8 to 33 months, mortality 5,5%. Laser vaporisation of gastrointestinal tract lesions is: 1. Alternative action in relation to other procedures regarding restoration of patency of the esophagus and the rectum in inoperable patients; 2. It is distinguished by short hospitalization time and low complications rate.
Esophageal Cancer, Rectal Cancer, Laser Vaporisation
To cite this article
Leszek Stefanski, Pawel Lampe, Laser Vaporization of Inoperable Esophageal and Rectal Cancer. Why We Use this Therapy, Journal of Surgery. Vol. 3, No. 1, 2015, pp. 4-7. doi: 10.11648/j.js.20150301.12
Wojciechowska U., Didkowska J., Zatoński W.: Nowotwory złośliwe w Polsce w 2008 roku; Krajowy Rejestr Nowotworów, Centrum Onkologii, Warszawa 2010.
Jih M., Kimyai-Asadi A.: Fractional photothermolysis: a review and update. Semin Cutan Med Surg. 2008 Mar;27(1):63-71.
Rao V., et al: Endoscopic laser ablation of advanced rectal carcinoma; Colorectal Dis. 2005; 7(1): 58-60
Courtney E., et al.: Eight years experience of high-powered endoscopic diode laser therapy for palliation of colorectal carcinoma. Colon Rectum. 2005 Apr;48(4):845-50.
Javle M. et al: Palliation of malignant dysphagia in esophageal cancer: a literature-based review. J Support Oncol. 2006 Sep;4(8):365-73, 379.
Courtney ED, Raja A, Leicester RJ.: Eight years experience of high-powered endoscopic diode laser therapy for palliation of colorectal carcinoma. Dis Colon Rectum. 2005 Apr;48(4):845-50.
Thompson AM. et al: Endoscopic palliative treatment for esophageal and gastric cancer: techniques, complications, and survival in a population-based cohort of 948 patients. Surg Endosc. 2004 Aug;18(8):1257-62. Epub 2004 May 28. PubMed PMID: 15164283.
Kozarek RA.: Endoscopic palliation of esophageal malignancy. Endoscopy. 2003 Aug;35(8):S9-13.
Lambert R.: Treatment of esophagogastric tumors. Endoscopy. 2003 Feb;35(2):118-26.
Aly EA, Burgess P.: Use of laser in the relief of malignant dysphagia: a district hospital experience. Dig Surg. 2002;19(1):3-8.
Imran H.: Management of stage IV rectal cancer: Palliative opions; World J Gastroenterol 2011 February 21; 17(7): 835-847
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
Tel: (001)347-983-5186